Contact
Please use this form to send email to PR contact of this press release:
FDA approves first interchangeable biosimilar to Perjeta to treat certain types of breast cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA approves first interchangeable biosimilar to Perjeta to treat certain types of breast cancer
TO: